Current and future cholera vaccines.
Current and future cholera vaccines.
Vaccine. 2019 Dec 24;:
Authors: Shaikh H, Lynch J, Kim J, Excler JL
Abstract
Cholera remains a major global public health problem that is primarily linked to insufficient access to safe water and proper sanitation. Oral Cholera Vaccine (OCV) has been recommended as an additional public health tool along with WASH in cholera endemic countries and in areas at risk for outbreaks. The new generation OCV is safe and offers good protection in older children and adults while limited protection in younger children less than five years of age has been observed. The combination of direct vaccine protection and vaccine herd immunity effects makes OCV highly cost-effective and, therefore, attractive for use in developing countries. Additionally, in recent studies OCV was safe in pregnant women, supporting its use in pregnant women in cholera endemic countries. However, knowledge need to be developed for current vaccines for their prolonged duration of protection and vaccines need improvements for better immune response in younger children. A single dose vaccination regimen would be more cost-effective and easier to deliver. Recent approaches have focused on designing genetically attenuated cholera strains for use in single-dose cholera vaccines. The global demand for OCV has been boosted by the WHO recommendation to use OCV and is driven largely by epidemics and outbreaks and has been increasing due to the av...
Source: Vaccine - Category: Allergy & Immunology Authors: Shaikh H, Lynch J, Kim J, Excler JL Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Children | Cholera | Emergency Medicine | Endemics | Epidemics | Epidemiology | Genetics | International Medicine & Public Health | Outbreaks | Pregnancy | Study | Vaccines | Women